.png){kind=logo}
GC Asia
IPOs under microscope as Chr Hansen and Life get ready
The EMEA IPO market will face a stern test next week when Danish biotech firm Chr Hansen and South African healthcare group Life price their IPOs, which together hope to raise around $1.8bn.
No deals were due to be priced this week so Europe was spared an IPO wipeout as markets swung wildly. The EuroStoxx 50 index went from 2,764.31 on May 12 to 2,488.50 on Tuesday — a fall of 10% — before recovering later during the week to close
...
Already a subscriber? Login
-
Latest news from Equity
-
Grand Pharmaceutical pockets HK$1bn from share sale
08.00 AM -
Corrected: Shriram Transport Finance’s rights issue wrapped up
06.30 AM -
EU: the musical, Hong Kong: the swan song, and a menacing ballet
31 Jul 2020 -
IAG launches rights issue to tackle ‘worst case’ coronavirus scenario
31 Jul 2020 -
Tigermed to snag top-end price for $1.4bn Hong Kong IPO
31 Jul 2020
-
-
Latest news from Equity
-
Grand Pharmaceutical pockets HK$1bn from share sale
08.00 AM -
Corrected: Shriram Transport Finance’s rights issue wrapped up
06.30 AM -
EU: the musical, Hong Kong: the swan song, and a menacing ballet
31 Jul 2020 -
IAG launches rights issue to tackle ‘worst case’ coronavirus scenario
31 Jul 2020 -
Tigermed to snag top-end price for $1.4bn Hong Kong IPO
31 Jul 2020
-
Further Reading
-
Follow-ons/Rights Issues
Grand Pharmaceutical pockets HK$1bn from share sale
-
Follow-ons/Rights Issues
Corrected: Shriram Transport Finance’s rights issue wrapped up
-
Comment
EU: the musical, Hong Kong: the swan song, and a menacing ballet
-
Follow-Ons/Rights Issues
IAG launches rights issue to tackle ‘worst case’ coronavirus scenario
